CHRIS A. RALLIS - 12 Jun 2023 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Role
Director
Signature
/s/ Chris A. Rallis
Issuer symbol
FENC
Transactions as of
12 Jun 2023
Net transactions value
$0
Form type
4
Filing time
13 Jun 2023, 11:42:04 UTC
Previous filing
19 May 2023
Next filing
06 Jul 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FENC Stock Option Award $0 +20,000 +11% $0.000000 209,186 12 Jun 2023 Common shares 20,000 $8.78 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 12, 2023, Chris Rallis was granted a non-qualified stock option to purchase 20,000 shares of the issuer's common shares pursuant to the issuer's Equity Incentive Plan.
F2 The option is 100% vested of date of grant.